C86.5 Angioimmunoblastic T-cell lymphoma

Name of the Condition

• Angioimmunoblastic T-cell lymphoma
• ICD-10 Code: C86.5

Summary

Angioimmunoblastic T-cell lymphoma (AITL) is a rare type of non-Hodgkin lymphoma that originates from T-cells. It is characterized by a proliferation of abnormal T-cells and prominent vascular changes, often involving lymph nodes and sometimes other organs. The disease may present with systemic symptoms and can progress if left untreated.

Causes

The exact cause involves genetic mutations in T-cells leading to uncontrolled proliferation. Epstein-Barr virus (EBV) infection is frequently associated with AITL, and immune system dysregulation may contribute to its development. The role of environmental factors or other infections remains under investigation.

Risk Factors

• Epstein-Barr virus (EBV) infection
• Advanced age (most commonly diagnosed in older adults)
• Male gender
• Immunosuppression (e.g., from medications or HIV)
• Prior exposure to certain chemicals or radiation

Symptoms

• Painless swollen lymph nodes
• Fever, night sweats, or unexplained weight loss
• Skin rashes or lesions
• Fatigue or weakness
• Abdominal pain or swelling
• Respiratory symptoms (if lung involvement)
• Hepatosplenomegaly (enlarged liver or spleen)

Diagnosis

Diagnosis involves a physical examination, followed by biopsy of affected tissue to confirm lymphoma type. Imaging (CT, PET) assesses disease extent, and blood tests evaluate cell counts and organ function. Flow cytometry and immunohistochemistry help identify T-cell abnormalities, while molecular testing may detect EBV or genetic markers.

Treatment Options

Treatment typically includes chemotherapy, often with regimens like CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Stem cell transplantation may be considered for eligible patients. Supportive care addresses symptoms like fever or fatigue. Clinical trials may offer additional options for refractory cases.

Prognosis and Follow-Up

Prognosis varies, with some patients responding to treatment while others experience relapse. Regular follow-up with imaging and blood tests monitors disease status. Long-term survival depends on factors like age, overall health, and response to therapy. Supportive care and symptom management are integral to follow-up.

Complications

• Disease progression or relapse
• Infections due to immunosuppression
• Organ dysfunction (e.g., liver or kidney)
• Secondary malignancies
• Treatment-related side effects (e.g., neuropathy, cytopenias)

Lifestyle & Prevention

No specific prevention exists, but maintaining overall health may support immune function. Avoiding known risk factors like unnecessary immunosuppression (when possible) and seeking prompt care for persistent symptoms may aid early detection.

When to Seek Professional Help

Consult a healthcare provider for unexplained lymph node swelling, persistent fever, night sweats, or unexplained weight loss. Seek urgent care for severe symptoms like difficulty breathing, abdominal pain, or signs of infection.

Tips for Medical Coders

Document the diagnosis of angioimmunoblastic T-cell lymphoma with code C86.5. Ensure clinical documentation supports the diagnosis, including biopsy results, imaging findings, and relevant symptoms. Verify that the code aligns with the specific lymphoma type and exclude other T-cell lymphoma codes unless documented.